Immunos Therapeutics AG

ImmunOs Therapeutics AG operates as a biotechnology company. The Company discovers, develops, and commercializes novel human immunomodulatory proteins for cancer treatment that effects anti-tumor but also remodel the tumor microenvironment and improve existing immunotherapies. ImmunOs Therapeutics serves customers in Switzerland.